BTAX (Biostax) ROCE % : 0.00% (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Biostax ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biostax's annualized ROCE % for the quarter that ended in Jun. 2024 was 0.00%.

Biostax ROCE % Historical Data

The historical data trend for Biostax's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostax ROCE % Chart

Biostax Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

Biostax Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Biostax ROCE % Calculation

Biostax's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-2.194	/	( ( (0.964 - 3.477)	+	(0.035 - 4.563) )	/ 2 )
	=	-2.194	/	( (-2.513	+	-4.528)	/ 2 )
	=	-2.194	/	-3.5205
	=	62.32 %

Biostax's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	-1.404	/	( ( (0.008 - 4.867)	+	(0.005 - 5.308) )	/ 2 )
	=	-1.404	/	( ( -4.859	+	-5.303 )	/ 2 )
	=	-1.404	/	-5.081
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

Biostax (OTCPK:BTAX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biostax ROCE % Related Terms

Thank you for viewing the detailed overview of Biostax's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biostax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792

Website

https://www.biostaxcorp.com

Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.

Executives

Glen A Farmer	officer: Chief Financial Officer	20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
H. Louis Salomonsky Jr. Revocable Trust	10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Henry Louis Salomonsky	director, 10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Kelly O'brien Wilson	10 percent owner, officer: COO and ICEO and IP	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
James Norman Curley	other: Member of 10% owner group	410 DAHLIA AVE, CORONA DEL MAR CA 92625
Empower Insurance Corp Ltd	other: Member of 10% owner group	1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ
Global Reverb Corp	10 percent owner, other: Member of 10% owner group	100 S EOLA DR, UNIT 1703, ORLANDO FL 32801
Paul Puskadi	other: Member of 10% owner group	2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004
Deane Rhodes	other: Member of 10% owner group	9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406
Roger Dale Bozarth	other: Member of 10% owner group	9028 GREAT HERON CIR, ORLANDO FL 32836
Joel Yanowitz	other: Member of 10% owner group	100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925
Rogoff Family Trust Dtd	other: Member of 10% owner group	20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255
George Sasko	other: Member of 10% owner group	515 WESTCHESTER DR, STE D, CAMPBELL CA 95008
Raster Investments, Inc	other: Member of 10% owner group	2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736
Robert Jackman Dailey	other: Member of 10% owner group	401 FIRST STREET, LOS ALTOS CA 94022